Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 600 30 109.5 |
96 | EP file number | EAKZ | 00 93 8074.2 |
86 | WO file number | WAKZ | PCT/US00/15235 |
97 | EP publication number | EPN | 1183020 |
87 | WO publication number | WPN | 2000074666 |
54 | Designation/title | TI | Verwendung von (-)(3-Trihalomethylphenoxy)(4-halophenyl)essigsäure-Derivaten zur Behandlung von Insulinresistenz, Typ II Diabetes, Hyperlipidämie und Hyperurikämie |
51 | IPC main class | ICM (ICMV) | A61K 31/00 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 3/10 (2006.01) |
22 | DE application date | DAT | Jun 2, 2000 |
96 | EP application date | EAT | Jun 2, 2000 |
86 | WO application date | WAT | Jun 2, 2000 |
43 | Date of first publication | OT | Dec 14, 2000 |
| Date of publication of grant | PET | Aug 16, 2006 |
71/73 | Applicant/owner | INH | CYMABAY THERAPEUTICS, INC.(n.d.Ges. d. Staates Delaware), Hayward, Kalif., US; Diatex, Inc., San Antonio, Tex., US |
72 | Inventor | IN | LUSKEY L., Kenneth, Saratoga, CA 95070, US; LUO, Jian, Brisbane, CA 94005, US |
74 | Representative | VTR | Patentanwälte Bressel und Partner mbB, 10785 Berlin, DE |
10 | Published DE documents | DEPN | Original document:
DE000060030109T2 Searchable text:
DE000060030109T2 |
| Address for service | | Patentanwälte Bressel und Partner mbB, 10785 Berlin, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 325997 Jun 4, 1999
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
81 | Designated WO countries | WDS | LT, SI, AL, LV, MK, RO |
| Published EP/WO documents | EPWOPN | Original document:
EP000001183020 Searchable text:
EP000001183020 Original document:
EP000001183020B1 Searchable text:
EP000001183020B1 Original document:
WO002000074666 Searchable text:
WO002000074666 |
43 | Date of first publication | EVT | Dec 14, 2000 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 5, 2025 (Show all update days)(Hide all update days)- Jan 5, 2025
- Procedures: New representative details, New representative details, 29.01.2014: deleted
- Aug 13, 2019; Mar 28, 2019; Feb 19, 2019; Oct 18, 2018; Jul 11, 2018; Jun 13, 2017; Jun 9, 2016; Oct 23, 2015; Jun 11, 2015; Mar 31, 2015; Jul 9, 2014; Jun 13, 2014; Mar 6, 2014; Jan 30, 2014; Aug 7, 2013; Jul 10, 2013; Jun 11, 2013; Jan 23, 2013
- Historical data not available for this/these date(s)
- Sep 29, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 10)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jan 29, 2014 |
| Issue number | HN | 10 |
| Year | PJ | 2014 |
| Publication date | VT | Mar 6, 2014 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 2 |
71/73 | Applicant/owner | INH | CYMABAY THERAPEUTICS, INC.(n.d.Ges. d. Staates Delaware), Hayward, Kalif., US; Diatex, Inc., San Antonio, Tex., US |
71/73 | Previous applicant/owner | INHF | Metabolex, Inc., Hayward, Calif., US, Diatex, Inc., San Antonio, Tex., US |